My bad A2M and BAL all good. Those that need to re-register are below. Also Nestle and Mead are on the Europe list so yeah looks like a market culling to me.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come